What is the CanAssist Breast test?

CanAssist Breast is a prognostic test that helps predict the risk of breast cancer recurrence and supports oncologists in personalizing treatment plans.

Who can benefit from the CanAssist Breast test?

It is suitable for patients diagnosed with early-stage, hormone receptor-positive breast cancer to determine their recurrence risk.

How accurate is the CanAssist Breast test?

CanAssist Breast has been validated on South Asian and Caucasian populations, demonstrating high accuracy in predicting recurrence risk.

Clinical Research Validating Breast Cancer Recurrence Risk Tests

GAPM; Gujarat Association of Pathologists and Microbiologists (GAMP)

Events and Conferences

December, 2023

Talk given by Dr. Manjiri Bakre on 'Does every breast cancer patient need chemotherapy? And Role of “Made in India” innovative tests in decision making to a talented audience of Pathologists and Microbiologists at GAPM 2023, in Vadodara

View

OFCON

Events and Conferences

December, 2023

Dr. Rohan Khandelwal shared groundbreaking insights about the CanAssist Breast Test at OFCON Conference, New Delhi

View

Annual conference of the Asian Society of Mastology

Events and Conferences

November, 2023

Talk given by Dr. Mandeep Singh at ASOMACON, Dehradun

View

Indian Cancer Conference

Events and Conferences

November, 2023

Presented an Advisory about the CAB test at ICC, Mumbai

View

CME at Udaipur, Rajasthan

Events and Conferences

October, 2023

Dr. D. G. Vijay explained data on CanAssist Breast in a CME at Udaipur, Rajasthan

View

ASICON

Events and Conferences

October, 2023

Talk given by Dr. D. G. Vijay at Association of Surgeons of India ASICON

View

BMC Cancer Part of Springer Nature

Scientific Publication by Renowned Oncologists Worldwide

July, 2023

Purvish Parikh et al: Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method

View

Scientific Publications